Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
DOSSIER Updates May 2012 Web site: http://statepi.jhsph.edu/macs/macs.html Prepared by CAMACS Fax: 410-955-7587 The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute and the National Heart, Lung and Blood Institute. UO1-AI-35042, UL1RR025005, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041. May 2011 CAMACS • Planning and design of studies • Coordination of data acquisition – Form development – Codebooks – Data transfer • Standardization and data management – Edits and updates – Data security • Data analysis, statistical computing and methodological research September 1995 , AB (negs) Continuous Outcome Ascertainment • Seroconversion (seronegatives only) • Clinical Outcomes (medical records confirmation) – AIDS diagnoses – Non-AIDS diagnoses • • • • • • • Cardiovascular disease Cerebrovascular disease Kidney disease Liver disease Lung infection, bacterima, septicemia Malignancies Neurologic – Mortality November 2004 Composition & Size of Cohort # Participants (thousands) 5 Seronegative Seroconverter 4 Seroprevalent 3 2 1 0 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 Visit (Calendar year) * 1710 have been administratively censored May 2011 MACS Database (as of May 2012) Publications (published & in press) 11,229 Participants 6,992 Person-Years 89,752 Variables 12,305 Repository aliquots 1,638,409 (plasma, serum, cells, urine) HIV+ HIV- Person-Visits 58,287 74,588 CD4 Measurements 53,641 59,619 HIV RNA Measurements 35,822 1,218 May 2012 Retention of LA MACS Participants (including active and those who died; through 09/30/07) % HIV- % HIV+ % Seroconverters 92.6 67.4 76.1 94.0 78.6 84.3 87.3 100 81 Total 85.3 Combined = 1530/1728=88.5% 90.4 87.3 European-American African-American Hispanic-American Incidence* of Seroconversion in the MACS by Center Kingsley, Zhou, . . ., Muñoz - AJE 1991 (update) 60 Incidence Baltimore 50 Chicago 40 Pittsburgh Los Angeles 30 20 10 0 84 86 88 90 92 94 Calendar Time (years) * Incidence = # of seroconverters per 1,000 person-semesters September 1995 June 1997 Likelihood of Developing AIDS in Three Years Mellors, Muñoz, . . ., Rinaldo - Ann Int Med 1997 100% 80% 60% 40% <200 201-350 351-500 CD4+ 501-750 T-lymphocyte >750 Count 20% 0% >30K >55K 10K – 30K 3K – 10K 501 – 3K 20K – 55K 7K – 20K 1501 – 7K <500 bDNA <1501 RT-PCR (cells/mm3) Plasma Viral Load (copies/ml in thousands) June 1997 Proportion Surviving AIDS by Year of Diagnosis Assumed currently alive at 6/30/99 if contacted since 6/30/98 Jacobson, Kirby, . . ., Schrager - AJE 1993 (update) Proportion Surviving AIDS 1.0 1984-85 1986-87 1988-90 1991-94 1995-98 0.8 0.6 0.4 0.2 0.0 0 2 4 6 8 10 Years After Initial Clinical AIDS Diagnosis October 1999 MACS Subgroups of Particular Interest • Long-term seropositive individuals with minimal declines in CD4 levels • Seropositive individuals with rapid declines in CD4 levels • Long-term survivors with low CD4 levels • Seroconverters • High-risk seronegatives • Seropositives on treatment • >55 years old Key Factors in the Success of the MACS • The commitment and sacrifice of the participants • The staff members of the MACS • Strong laboratory support UCLA MACS Staff John Oishi, Study Coordinator Kevin Barrett, Data Manager/Programmer Max Hechter, Coordinator Charles Doran, Administrative Specialist Nicole Hadjioannou, SRA, Clinical Follow-up MACS Clinic Staff LA Men’s Study, Wilshire Site –Dennis Miles, Site Manager –May Htike, Lead Examiner –Daniel Cheng, SRA, Senior Interviewer –Tuan Nguyen, Examiner –Alan Ernst, Interviewer Los Angeles Gay & Lesbian Center –Eduardo Mercado, Coordinator –Ray Mercado, Coordinator Harbor-UCLA Medical Center –Carlos Aquino, Coordinator –Lisa Siquieros, Assistant Coordinator –Gilbert Papilla, Assistant Coordinator LA MACS Investigators • • • • • • • • • • • • • • Beth Jamieson John Fahey Anthony Butch Steve Young Najib Aziz Oto Martinez Rita Effros Barbara Visscher Jonathan Braun Eric Miller Mallory Witt Dorothy Wiley Harry Vinters Many students Andrew Levine Jordan Lake Otto Yang Peter Anton Elizabeth Breen Karl Goodkin Mathew Wright Richard Wight Pamina Gorbach Steve Shoptaw Zuofeng Zhang Shenaz Hussain